ニュース

The FDA is requiring COVID vaccine makers Pfizer and Moderna to update their warnings about the possible risk of myocarditis ...
The Food and Drug Administration says it has decided to continue approving COVID-19 vaccine updates for seniors and others at ...
Here’s how COVID-19 vaccine guidance is changing in the U.S. For people at high risk of severe COVID-19. The process of ...
The House Judiciary Committee revealed Thursday that Pfizer’s former Global Head of Vaccines Research and Development, Dr.
The FDA plans to require new clinical trials for approval of annual COVID-19 boosters for healthy Americans under 65.
In this week’s edition of InnovationRx, we look at the FDA's new rules on Covid-19 vaccines, Novartis’s acquisition strategy, ...
U.S. health officials knew about the risks of myocarditis from COVID-19 vaccines but downplayed the concern and delayed informing the public about the risks of taking the jab—that is according to a ...
ウォール・ストリート・ジャーナル日本版 on MSN6 日
ファイザーのコロナワクチンで新疑惑、米下院委が調査
米議員らは、製薬大手ファイザーが新型コロナワクチンの臨床試験(治験)結果の公表を2020年の米大統領選が終わるまで待ったかどうかを調査している。下院司法委員会の新たな書簡によると、ファイザー元社員の科学者が実験を「意図的に遅らせる」取り組みへの関与を認めたとする新たな疑惑が浮上した。
The U.S. Food and Drug Administration (FDA) is changing the game on COVID-19 vaccines. Instead of approving yearly boosters ...
The US Food and Drug Administration (FDA) announces new regulatory guidelines for future COVID-19 vaccines and booster shots.
The rollout of updated Covid vaccines for healthy children and adults this fall is likely to be delayed after the FDA said it ...
China continues to be a source of innovation as Pfizer strikes biggest pact yet; HHS provides more info on Trump’s Most Favored Nation executive order; FDA Commissioner Marty Makary and CBER director ...